Immunohistochemical stains in mohs surgery

Dermatologic Surgery

Volumn 35, Issue 7, 2009, Pages 1023-1034

  Stranahan, Donald ^b   Cherpelis, Basil S ^a,b   Glass, L Frank ^b   Ladd, Sharron ^b   Fenske, Neil A ^b  

^a MDC 79 ^*  (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD34 ANTIGEN; CYTOKERATIN; CYTOKERATIN 17; CYTOKERATIN 7; EOSIN; GLYCOPROTEIN; HEMATOXYLIN; HIGH MOBILITY GROUP PROTEIN; HIGH MOBILITY GROUP PROTEIN 45; MELAN A; MELANOMA ANTIGEN; MICROPHTHALMIC TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY; PROTEIN S 100; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIBODY TITER; BASAL CELL CARCINOMA; CHEMOSURGERY; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC ACCURACY; FROZEN SECTION; GRANULAR CELL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; PAGET SKIN DISEASE; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STAINING; TRICHILEMMOMA; TUMOR CELL; TUMOR RECURRENCE;

ANTIBODIES; COLORING AGENTS; HUMANS; IMMUNOHISTOCHEMISTRY; MOHS SURGERY; NEOPLASM, RESIDUAL; SKIN NEOPLASMS;

EID: 67650739289     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01179.x     Document Type: Review

References (45)

1. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 1995 33 : 271 8.
2. Robinson JK, Gottschalk R. Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Arch Dermatol 1984 120 : 199 203.
3. Mondragon RM, Barrett TL. Current concepts: the use of immunoperoxidase techniques in Mohs micrographic surgery. J Am Acad Dermatol 2000 43 : 66 71. (Pubitemid 30439715)
4. Salmon RM. The use of monoclonal antibody stains in Mohs micrographic surgery. Aust J Dermatol 1997 38 : 44 5.
5. Widmann FK, Itatani CA. An Introduction to Clinical Immunology and Serology. 2nd ed. Philadelphia : F. A. Davis Company 1989.
6. Zachary CB, Rest EB, Furlong SW, et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol 1994 20 : 530 5.
7. Zalla MJ, Lim KK, DiCaudo DJ, et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000 26 : 771 84.
8. Griego RD, Zitelli JA. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg 1998 24 : 1003 6.
9. Gross EA, Andersen WK, Rogers GS. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol 1999 135 : 15 7.
10. Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: university of Minnesota experience. Dermatol Surg 2006 32 : 690 6.
11. Albertini JG, Elston DM, Libow LF, et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002 28 : 656 65.
12. Kelley LC, Starkus LS. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002 46 : 78 84. (Pubitemid 34073482)
13. Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol 2006 142 : 871 6.
14. Geisse JK. Re: questionable utility of melan-A/Mart-1 immunoperoxidase staining while doing Mohs surgery for melanoma. Dermatol Surg 2005 31 : 495. (Pubitemid 40489322)
15. El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actininc keratosis. Am J Dermatopathol 2004 26 : 364 6.
16. Cherpelis BS, Moore R, Ladd S, et al. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol. Dermatol Surg 2009 35 : 207 13.
17. Bricca GM, Brodland DG, Zitelli JA. Immunostaining melanoma frozen sections: the 1-hour protocol. Dermatol Surg 2004 30 : 403 8.
18. Ohsie SJ, Sarantopoulos GP, Cochrane AJ, et al. Immunohistochemical characteristics of melanoma. J Cut Pathol 2008 35 : 433 44.
19. Kimyai-Asadi A, Ayala GB, Goldberg LH, et al. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections. Dermatol Surg 2008 34 : 498 500.
20. King R, Weilbaecher KN, McGill G, et al. Microphthalmia transcription factor, a sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 1999 155 : 731 8.
21. Glass LF, Clark GS, Higgins B, et al. Frozen tissue immunohistochemistry of melanocytes by microphthalmic transcription factor in chronically photodamaged skin. J Cutan Pathol, 2009, in press.
22. Jacques C, de Aquinao AM, Ramos-e-Silva M. Cytokeratins and dermatology. Skinmed 2005 4 : 354 60 quiz 360-1.
23. Jiminez FJ, Grichnik JM, Buchanan MD, et al. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol 1995 32 : 89 94.
24. Cherpelis BS, Turner L, Ladd S, et al. 19 minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery. Dermatol Surg, 2009, in press.
25. Smeets NW, Stavast-Kooy AJ, Krekels GA, et al. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. Dermatol Surg 2003 29 : 375 7.
26. Ko CJ, McNiff JM, Glusac EJ. Squamous cell carcinomas with single cell infiltration: a potential diagnostic pitfall and the utility of MNF116 and p63. J Cutan Pathol 2008 35 : 353 7.
27. Albregts T, Orengo I, Salasche S, et al. Squamous cell carcinoma in a patient with chronic lymphocytic leukemia: an intraoperative diagnostic challenge for the Mohs surgeon. Dermatol Surg 1998 24 : 269 72.
28. Latza U, Niedobitek G, Schwarting R, et al. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990 43 : 213 9.
29. Tellechea O, Reis JP, Domingues JC, et al. Monoclonal antibody Ber EP4 distinguises basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 1993 15 : 452 5.
30. Kist D, Perkins W, Christ S, et al. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation. Dermatol Surg 1997 23 : 1067 70.
31. Katz KH, Helm KF, Billingsley EM, et al. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery. J Am Acad Dermatol 2001 45 : 231 8.
32. Gloster HM. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996 35 : 355 74.
33. Garcia C, Viehman G, Hitchcock M, et al. Dermatofibrosarcoma protuberans treated with Mohs surgery. Dermatol Surg 1996 22 : 177 9.
34. Jiminez FJ, Grichnik JM, Buchanan MD, et al. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol 1994 20 : 687 9.
35. Youn J, Albertini JG. Atrophic dermatofibrosarcoma protuberans: case report, review, and proposed molecular mechanisms. J Am Acad Dermatol 2003 49 : 761 4.
36. Harris DS, Kist DA, Bloom K, et al. Rapid staining with carcinoembryonic antigen aids limited excision of extramammary Paget's disease treated with Mohs surgery. J Dermatol Surg Oncol 1994 20 : 260 4.
37. Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget's disease A report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991 67 : 933 8.
38. O'Conner WJ, Lim KK, Zalla MJ, et al. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's disease. Dermatol Surg 2003 29 : 723 7.
39. Smith KJ, Tuur S, Corvette D, et al. Cytokeratin 7 staining in mammary and extramammary Paget's disease. Mod Pathol 1997 10 : 1069 74.
40. Carson HJ, Gattuso P, Raslan WF, et al. Mucinous carcinoma of the eyelid: an immunohistochemical study. Am J Dermatopathol 1995 17 : 494 9.
41. Bellezza G, Sidoni A, Bucciarelli E. Primary cutaneous mucinous carcinoma of the skin. Am J Dermatopathol 2000 22 : 166 70.
42. Marra DE, Schanbacher CF, Torres A. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control. Dermatol Surg 2004 30 : 799 802. (Pubitemid 38657978)
43. Smith SB, Farley MF, Albertini JG, et al. Mohs micrographic surgery for granular cell tumor using S-100 immunostain. Dermatol Surg 2002 28 : 1076 8.
44. Allee JE, Cotsarelis G, Solky B, et al. Multiply recurrent trichilemmal carcinoma with perineural invasion and cytokeratin 17 positivity. Dermatol Surg 2003 29 : 886 9.
45. Robinson JK. Current histologic preparation methods for Mohs micrographic surgery. Dermatol Surg 2001 27 : 555 60.